Journal of Hepatology
Volume 48, Issue 1 , Pages 68-73 , January 2008

Evolution in the management of acute liver failure-associated aplastic anaemia in children: A single centre experience

  • Nedim Hadžić

      Affiliations

    • Institute of Liver Studies, King’s College London School of Medicine at King’s College, London, UK
    • Corresponding Author InformationCorresponding author. Address: Paediatric Liver Centre, Variety Club Children’s Hospital, King’s College Hospital, Denmark Hill, London SE5 9RS, UK. Tel.: +44 0 2032994120; fax: +44 0 2032994228.
    • ,
  • Susan Height

      Affiliations

    • Department of Haematology, King’s College London School of Medicine at King’s College, London, UK
    • ,
  • Sarah Ball

      Affiliations

    • Department of Haematology, St. George’s Hospital, London, UK
    • ,
  • Mohamed Rela

      Affiliations

    • Institute of Liver Studies, King’s College London School of Medicine at King’s College, London, UK
    • ,
  • Nigel D. Heaton

      Affiliations

    • Institute of Liver Studies, King’s College London School of Medicine at King’s College, London, UK
    • ,
  • Paul Veys

      Affiliations

    • Bone Marrow Transplant Unit, Great Ormond Street Hospital for Children, London, UK
    • ,
  • Giorgina Mieli-Vergani

      Affiliations

    • Institute of Liver Studies, King’s College London School of Medicine at King’s College, London, UK

Received 1 May 2007 ,Revised 22 July 2007 ,Accepted 1 August 2007.

References 

  1. Stock PG, Steiner ME, Freese D, Sharp H, Ascher NL. Hepatitis-associated aplastic anemia after liver transplantation. Transplantation. 1987;43:595–597
  2. Tzakis AG, Arditi M, Whitington PF, Yanaga K, Esquivel C, Andrews WA, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med. 1988;319:393–396
  3. Schlitt HJ, Ringe B, Rodeck B, Burdelski M, Kuse E, Pichlmayr R. Bone marrow dysfunction after liver transplantation for fulminant non-A, non-B hepatitis. High risk for young patients.. Transplantation. 1992;54:936–937
  4. Cattral MS, Langnas AN, Markin RS, Antonson DL, Heffron TG, Fox IJ, et al. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology. 1994;20:813–818
  5. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS. Hepatitis-associated aplastic anemia. N Engl J Med. 1997;336:1059–1064
  6. Tung J, Hadzic N, Layton M, Baker AJ, Dhawan A, Rela M, et al. Bone marrow failure in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2000;31:557–561
  7. Itterbeek P, Vandenberghe P, Nevens F, Fevery J, Aerts R, Yap SH, et al. Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature. Transpl Int. 2002;15:117–123
  8. Molina RA, Katzir L, Rhee C, Ingram-Drake L, Moore T, Krogstad P, et al. Early evidence of bone marrow dysfunction in children with indeterminate fulminant hepatic failure who ultimately develop aplastic anemia. Am J Transplant. 2004;4:1656–1661
  9. Young NS, Maciejewski J. The patophysiology of acquired aplastic anaemia. N Engl J Med. 1997;336:1365–1372
  10. Yoto Y, Kudoh T, Asanuma H, Numazaki K, Tsutsumi Y, Nakata S, et al. Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection. Lancet. 1994;344:624–625
  11. Langnas AN, Markin RS, Cattral MS, Naides SJ. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology. 1995;22:1661–1665
  12. Sokal EM, Melchior M, Cornu C, Vandenbroucke AT, Buts JP, Cohen BJ, et al. Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet. 1998;352:1739–1741
  13. Dhawan A, Cheeseman P, Mieli-Vergani G. Approaches to acute liver failure in children. Pediatr Transpl. 2004;8:584–588
  14. Devictor D, Desplanques L, Debray D, Ozier Y, Dubouset AM, Valayer J, et al. Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology. 1992;15:1156–1162
  15. Bhaduri BR, Mieli-Vergani G. Fulminant hepatic failure: pediatric aspects. Semin Liver Dis. 1996;16:349–355
  16. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med. 1991;324:1297–1304
  17. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85:3058–3065
  18. Hadzic N, Layton M, Heaton ND, Rela M, Baker AJ, Mieli-Vergani G. Anti-thymocyte globulin, cyclosporine A and granulocyte colony-stimulating factor for severe aplastic anaemia complicating paediatric liver transplantation. Eur J Pediatr. 1998;157:107–108
  19. Ball SE. The modern management of severe aplastic anaemia. Br J Hematol. 2000;110:41–53
  20. Young NS. Acquired aplastic anemia. Ann Intern Med. 2002;136:534–546
  21. Bansal S, Dhawan A. Acute liver failure. Indian J Pediatr. 2006;73:931–934
  22. Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet. 2004;364:1690–1698
  23. Wong S, Young NS, Brown KE. Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis. 2003;187:1581–1586
  24. Kojima S, Matsuyama K, Kodera Y, Okada J. Circulating activated suppressor T lymphocytes in hepatitis-associated aplastic anaemia. Br J Haematol. 1989;1:147–151
  25. Lu J, Basu A, Melenhorst J, Young NS, Brown KE. Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood. 2004;103:4588–4593
  26. Deshpande RR, Rela M, Girlanda R, Bowles MJ, Muiesan P, Dhawan A, et al. Long-term outcome of liver retransplantation in children. Transplantation. 2002;74:1124–1130
  27. Kiem HP, McDonald GB, Myerson D, Spurgeon CL, Deeg HJ, Sanders JE, et al. Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors. Biol Blood Marrow Transpl. 1996;2:93–99

☆ The authors declare that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

☆☆ This work was presented as a poster at the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) in Boston, USA, 26–31 October 2006.

PII: S0168-8278(07)00565-X

doi: 10.1016/j.jhep.2007.08.017

Journal of Hepatology
Volume 48, Issue 1 , Pages 68-73 , January 2008

Article Tools